TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 1 filers reported holding TENAX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,698 | +27.9% | 276,814 | +100.0% | 0.00% | – |
| Q3 2022 | $24,000 | -42.9% | 138,407 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -62.5% | 138,407 | 0.0% | 0.00% | – |
| Q1 2022 | $112,000 | -21.1% | 138,407 | +1.5% | 0.00% | – |
| Q4 2021 | $142,000 | -41.1% | 136,404 | 0.0% | 0.00% | – |
| Q3 2021 | $241,000 | -18.6% | 136,404 | 0.0% | 0.00% | – |
| Q2 2021 | $296,000 | – | 136,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |